Dr. Hsin-Hsu Wu

PROFESSIONAL POST

1) 2007~ Attending Physian, Nephrology Department, Chang Gung Medical Center, Linkou

2) 2005~2007 Fellow, Nephrology Department, Chang Gung Medical Center, Linkou

3) 2002~2005 Resident doctor, Internal Medicine, Chang Gung Medical Center, Linkou

Education

1) 1995~2002 Taipei Medical University, M.D. Taipei, Taiwan

2)PhD candidate, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan, Taiwan

RESEARCH INTEREST

1) Nephrology

2) Immunology

3) Transplantation medicine

Research Project

1.      2011/10~2013/06 CMRP: CMRPG3A1041The in-vivo and in-vitro Innate Immunity to Polyomavirus BK infection

2. BK virus and Interferon pathway

3. Clinical nephrology

 4. Peritoneal dialysis related infection

Professional ACTIVITIES

Dec 2007: The 10th Congress of Asian Society of Transplantation, Pattaya Thailand

Mar 2008: Asia Pacific Peritoneal Dialysis College, Bangkok Thailand

Apr 2009: 3rd Asian Forum of Chronic Kidney Disease Initiative, Kaoshiung Taiwan

Aug 2009: Pacific Rim Renal Expert Group Meeting, Singapore

 

MAJOR BIBLIOGRAPHY  

Wu HH, Chang CT, Yen TH, Hung CC*A case of adrenal aldosteronoma with horseshoe kidney and duplicated inferior vena cava. Nephrol Dial Transplant 2005; 20: 2858-60(SCI IF: 3.371; Urology & Nephrology: 14/73)

2. H.-H Wu, Y.-C. Tian, C.-I. Huang, Y. –J. Chiang, S.-H. Chu, and P.-C. Lai*: HLA Class I Antibodies in Patients Awaiting Kidney Transplantation and the Association With Renal Graft Survival. Transplant Proc. 2008 Sep;40(7):2191-4(SCI IF: 0.952; Surgery 130/198)

3. Wu HH, Li IJ, Weng CH, Lee CC, Chen YC, Chang MY, Fang JT, Hung CC, Yang CW, Tian YC*.Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients.PLoS One. 2013 Aug 1;8(8)(SCI IF: 3.730; MULTIDISCIPLINARY SCIENCES 7/56)

4. Wu MY, Wu IW, Wu SS, Lin JL*: Hemoperfusion as an effective alternative therapy for star fruit intoxication: a report of 2 cases. Am J Kidney Dis 2007; 49: e1-5(SCI IF: 5.294; Urology & Nephrology: 5/73)

5. Jenq CC. Tian YC. Wu HH. Hsu PY. Huang JY. Chen YC*. Fang JT. Yang CW.Effectiveness of oral and intravenous iron therapy in haemodialysis patients.International Journal of Clinical Practice. 62(3):416-22, 2008 Mar.(SCI IF: 2.427; Medicine: 30/151)

6. Li YJ, Weng CH, Lai WC, Wu HH, Chen YC, Hung CC, Yang CW, Tian YC*A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirusBK virusTransplantation. 2010 Feb 15;89(3):299-306 (SCI IF: 3.781; Surgery: 12/198)

7. Lee CC, Li IJ, Chen YC, Cheng JW, Wu HH, Weng CH, Fang JT, Tian YC* Comparable ten-year outcome in hemodialysis patients with hepatitis C virus and hepatitis B virus coinfection andsingle hepatitis B virus infection  Blood Purif. 2011;32(2):89-95 (SCI IF: 2.062; Urology & Nephrology: 30/73)

8. Yang HY, Yen TH, Lin CY, Chen YC, Pan MJ, Lee CH, Yu CC, Wu MS, Wu SS, Weng CH, Chen KH, Hung CC, Yang CW* Early identification of leptospirosis as an ignored cause of multiple organ dysfunction syndrome Shock. 2012 Jul;38(1):24-9  (SCI IF: 2.612; Surgery: 36/198)

9. Li YJ, Wu HH, Weng CH, Chen YC, Hung CC, Yang CW, Wang RY, Sakamoto N, Tian YC*Cyclophilin A and nuclear factor of activated T cells are essential in cyclosporine-mediated suppression of polyomavirus BK replication Am J Transplant. 2012 Sep;12(9):2348-62(SCI IF:6.192; Transplantation: 1/26)

10. Huang WK, Fan PC, Chen YC, Tian YC, Kang SC, Hsueh S, Wu HH, Chang CH, Fang JT*Henoch-Schönlein purpura with intussusception in an adult Am J Med Sci. 2012 Oct;344(4):337-9 (SCI IF: 1.334; Medicine: 66/151)

 

 

 

 

 

 

 

 
 
Quick Links

Back To Top